Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy

被引：112
|
作者：
Cavo, M [1 ]
Zamagni, E [1 ]
Cellini, C [1 ]
Tosi, P [1 ]
Cangini, D [1 ]
Cini, M [1 ]
Valdrè, L [1 ]
Palareti, G [1 ]
Masini, L [1 ]
Tura, S [1 ]
Baccarani, M [1 ]
机构：
[1] Inst Hematol & Med Oncol Seragnoli, I-40138 Bologna, Italy
来源：
BLOOD | 2002年 / 100卷 / 06期
关键词：
D O I：
10.1182/blood-2002-06-1674
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2272 / 2273
页数：2
相关论文
共 50 条
  • [11] Consolidation therapy of multiple myeloma with thalidomide-dexamethasone after intensive chemotherapy
    Alexanian, R
    Weber, D
    Giralt, S
    Delasalle, K
    ANNALS OF ONCOLOGY, 2002, 13 (07) : 1116 - 1119
  • [12] First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma
    Cavo, M
    Zamagni, E
    Tosi, P
    Cellini, C
    Cangini, D
    Tacchetti, P
    Testoni, N
    Tonelli, M
    De Vivo, A
    Palareti, G
    Tura, S
    Baccarani, M
    HAEMATOLOGICA, 2004, 89 (07) : 826 - 831
  • [13] Thalidomide plus dexamethasone for untreated newly diagnosed multiple myeloma patients and deep vein thrombosis.
    Jimenez, Victor H.
    Dominguez, Virginia J.
    Reynoso, Eduardo E.
    BLOOD, 2006, 108 (11) : 362B - 362B
  • [14] Superiority of first-line thalidomide-dexamethasone over vincristine-doxorubicin-dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma.
    Cavo, M
    Tacchetti, P
    Zamagni, E
    Tosi, P
    Cangini, D
    Cellini, C
    Testoni, N
    de Vivo, A
    Perrone, G
    Tura, S
    Baccarani, M
    BLOOD, 2004, 104 (11) : 416A - 416A
  • [15] How to prevent deep vein thrombosis in myeloma patients receiving thalidomide or lenalidomide
    Kastritis, Efstathios
    Dimopoulos, Meletios
    LEUKEMIA & LYMPHOMA, 2007, 48 (12) : 2295 - 2297
  • [16] Consolidation therapy of multiple myeloma with thalidomide-dexamethasone after intensive chemotherapy.
    Alexanian, R
    Weber, DM
    Giralt, S
    Delasalle, KB
    BLOOD, 2001, 98 (11) : 163A - 163A
  • [17] Lenalidomide versus thalidomide based regimens as first-line therapy for patients with multiple myeloma
    Zou, Yandun
    Sheng, Zhixin
    Niu, Shaona
    Wang, Huijuan
    Yu, Jinming
    Xu, Jingbo
    LEUKEMIA & LYMPHOMA, 2013, 54 (10) : 2219 - 2225
  • [18] Clinical efficacy of thalidomide containing regimens as a first-line therapy in patients with multiple myeloma
    Kim, Y. K.
    Lee, J. J.
    Lee, S. R.
    Shim, H. J.
    Ahn, J. S.
    Yang, D. H.
    Cho, S. H.
    Chung, I. J.
    Kim, D. H.
    Sohn, S. K.
    Shin, H. J.
    Kim, H. J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 177 - 177
  • [19] Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma
    Ludwig, Heinz
    Hajek, Roman
    Tothova, Elena
    Drach, Johannes
    Adam, Zdenek
    Labar, Boris
    Egyed, Miklos
    Spicka, Ivan
    Gisslinger, Heinz
    Greil, Richard
    Kuhn, Ingrid
    Zojer, Niklas
    Hinke, Axel
    BLOOD, 2009, 113 (15) : 3435 - 3442
  • [20] Thalidomide-dexamethasone versus melphalan-prednisolone as first line treatment in elderly patients with multiple myeloma:: Second interim analysis
    Ludwig, H.
    Tothova, E.
    Hajek, R.
    Drach, J.
    Labar, B.
    Egyed, M.
    Spicka, I.
    Gisslinger, H.
    Greil, R.
    Fridrik, M.
    Zojer, N.
    Kuhn, I.
    Linkesch, W.
    Mistrik, M.
    Jaksic, B.
    Kusec, R.
    Hinke, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 166 - 166
12345